Inve India ▾
OSOSELDEVICE

OSEL Devices Q2 FY26 results (Jul–Sep 2025) and concall

Healthcare · Concall AI · Call held 13 Nov 2025

OSEL Devices reported strong H1 FY26 performance driven by its LED and Hearing Aid segments, with the nascent Mobile Phone division showing rapid expansion and positive market reception. The company is strategically expanding its retail presence in hearing aids and mobile phones, leveraging competitive pricing and brand recognition. While short-term debt has increased for working capital, it is largely offset by mutual fund investments, and management anticipates overall growth of 20-25%.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q2 FY26: revenue up 188.2%, net profit up 200.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY24Q4 FY24Q2 FY25Q4 FY25Q2 FY26
Revenue51 82 87 99 147 +188%
EBITDA9 14 13 20 25 +178%
Net profit5 8 8 12 15 +200%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.